Suyeon Kim - Search Results

Year	Number of Results
2002	1
2004	1
2005	2
2006	3
2007	5
2008	3
2009	8
2010	4
2011	5
2012	4
2013	7
2014	6
2015	15
2016	12
2017	12
2018	16
2019	13
2020	16
2021	22
2022	26
2023	2

1

Prolotherapy for the patients with chronic musculoskeletal pain: systematic review and meta-analysis.

Bae G, Kim S, Lee S, Lee WY, Lim Y. Bae G, et al. Among authors: kim s. Anesth Pain Med (Seoul). 2021 Jan;16(1):81-95. doi: 10.17085/apm.20078. Epub 2020 Dec 16. Anesth Pain Med (Seoul). 2021. PMID: 33348947 Free PMC article.

2

LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells.

Kim S, Cho H, Hong SO, Oh SJ, Lee HJ, Cho E, Woo SR, Song JS, Chung JY, Son SW, Yoon SM, Jeon YM, Jeon S, Yee C, Lee KM, Hewitt SM, Kim JH, Song KH, Kim TW. Kim S, et al. Autophagy. 2021 Aug;17(8):1978-1997. doi: 10.1080/15548627.2020.1805214. Epub 2020 Aug 14. Autophagy. 2021. PMID: 32762616 Free PMC article.

3

Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle.

Oh SJ, Lee HJ, Song KH, Kim S, Cho E, Lee J, Bosenberg MW, Kim TW. Oh SJ, et al. Among authors: kim s. J Clin Invest. 2022 Mar 15;132(6):e147908. doi: 10.1172/JCI147908. J Clin Invest. 2022. PMID: 35104240 Free PMC article.

4

Copper-Catalyzed Enantiotopic-Group-Selective Allylation of gem-Diborylalkanes.

Kim M, Park B, Shin M, Kim S, Kim J, Baik MH, Cho SH. Kim M, et al. Among authors: kim s. J Am Chem Soc. 2021 Jan 20;143(2):1069-1077. doi: 10.1021/jacs.0c11750. Epub 2021 Jan 4. J Am Chem Soc. 2021. PMID: 33393768

5

Nanoscale interface engineering for solid oxide fuel cells using atomic layer deposition.

Seo J, Kim S, Jeon S, Kim S, Kim JH, Jung W. Seo J, et al. Among authors: kim s. Nanoscale Adv. 2022 Jan 11;4(4):1060-1073. doi: 10.1039/d1na00852h. eCollection 2022 Feb 15. Nanoscale Adv. 2022. PMID: 36131774 Free PMC article. Review.

6

Clinical development of CT-P10 and other biosimilar cancer therapeutics.

Kim WS, Coiffier B, Kwon HC, Kim S. Kim WS, et al. Among authors: kim s. Future Oncol. 2017 May;13(15s):31-44. doi: 10.2217/fon-2017-0155. Future Oncol. 2017. PMID: 28482700 Free article. Review.

7

Understanding the Tissue Specificity of ZIKV Infection in Various Animal Models for Vaccine Development.

Kim S, Shin HY. Kim S, et al. Vaccines (Basel). 2022 Sep 13;10(9):1517. doi: 10.3390/vaccines10091517. Vaccines (Basel). 2022. PMID: 36146595 Free PMC article. Review.

8

Direct-Writable and Thermally One-Step Curable "Water-Stained" Epoxy Composite Inks.

Kim S, Yang J, Kim J, Ryu SY, Cho H, Kim YS, Lee J. Kim S, et al. Polymers (Basel). 2022 Oct 6;14(19):4191. doi: 10.3390/polym14194191. Polymers (Basel). 2022. PMID: 36236139 Free PMC article.

9

PD-L1 siRNA-hyaluronic acid conjugate for dual-targeted cancer immunotherapy.

Kim S, Heo R, Song SH, Song KH, Shin JM, Oh SJ, Lee HJ, Chung JE, Park JH, Kim TW. Kim S, et al. J Control Release. 2022 Jun;346:226-239. doi: 10.1016/j.jconrel.2022.04.023. Epub 2022 Apr 25. J Control Release. 2022. PMID: 35461969 Free article.

10

Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes.

Lee HJ, Song KH, Oh SJ, Kim S, Cho E, Kim J, Park YG, Lee KM, Yee C, Song SH, Chang S, Choi J, Jung ST, Kim TW. Lee HJ, et al. Among authors: kim s. Nat Commun. 2022 Apr 19;13(1):2127. doi: 10.1038/s41467-022-29611-y. Nat Commun. 2022. PMID: 35440620 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results